Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3478050 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3HIF1AHSD17B10 | |
| SCHEMBL1225120 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3HIF1AHSD17B10 | |
| SCHEMBL1225118 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3HIF1AHSD17B10 | |
| SCHEMBL13510425 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3HIF1AHSD17B10 | |
| SCHEMBL31048385 | 0.98 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3HIF1AHSD17B10 | |
| SCHEMBL25446671 | 0.94 | — | — | |
| SCHEMBL3696352 | 0.94 | — | — | |
| SCHEMBL2647260 | 0.94 | — | — | |
| SCHEMBL5053538 | 0.94 | — | — | |
| SCHEMBL2646374 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569679-B2 | Treatment delivery system | WearOptimo Pty Ltd (AU) | 2026-03-10 | — | — | US | disclosed |
| US-12484814-B2 | Actuator system | WearOptimo Pty Ltd (AU) | 2025-12-02 | — | — | US | disclosed |
| US-20250025078-A1 | ELECTRODE ARRANGEMENT | WearOptimo Pty Ltd (AU) | 2025-01-23 | — | — | US | disclosed |
| CN-116747255-A | Cannabis pain-relieving gel and preparation method thereof | 黑龙江钲拓农业发展有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20230053962-A1 | ANALYTE MEASUREMENT SYSTEM | WearOptimo Pty Ltd (AU) | 2023-02-23 | — | — | US | disclosed |
| US-20230035892-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | FLAGSHIP PIONEERING, INC. | 2023-02-02 | — | — | US | disclosed |
| US-20220346679-A1 | ANALYTE MEASUREMENT SYSTEM | WearOptimo Pty Ltd (AU) | 2022-11-03 | — | — | US | disclosed |
| EP-4037552-A1 | ANALYTE MEASUREMENT SYSTEM | Wearoptimo Pty Ltd (AU) | 2022-08-10 | — | — | EP | disclosed |
| US-11274158-B2 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| US-20220033490-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING CHRNA6 INHIBITORS | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2022-02-03 | — | — | US | disclosed |
| US-8581178-B2 | Combined mass and differential mobility spectrometry and associated methods, systems, and devices | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-11-12 | — | — | US | disclosed |
| US-8384024-B2 | Tandem differential mobility spectrometers and mass spectrometer for enhanced analysis | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-02-26 | — | — | US | disclosed |
| US-20110133076-A1 | TANDEM DIFFERENTIAL MOBILITY SPECTROMETERS AND MASS SPECTROMETER FOR ENHANCED ANALYSIS | MILLER RAANAN A | 2011-06-09 | — | — | US | disclosed |
| WO-2010131058-A1 | PRODUCT FOR THE PROTECTION AGAINST HONEYBEE MITES, AND METHOD FOR THE PREPARATION OF THE ACTIVE SUBSTANCE | VON BARTHELDNE ABRI JUDIT (HU) | 2010-11-18 | — | — | WO | disclosed |
| US-7812305-B2 | Tandem differential mobility spectrometers and mass spectrometer for enhanced analysis | SIONEX CORPORATION (US) | 2010-10-12 | — | — | US | disclosed |
| US-20100048893-A1 | Substituted arylalkanoic acid derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20080149824-A1 | Tandem differential mobility spectrometers and mass spectrometer for enhanced analysis | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2008-06-26 | — | — | US | disclosed |
| US-20060289745-A1 | Combined mass and differential mobility spectrometry and associated methods, systems, and devices | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2006-12-28 | — | — | US | disclosed |
| US-4752554-A | Optical information recording medium | RICOH CO., LTD. (JP) | 1988-06-21 | — | — | US | disclosed |
| EP-0143992-A1 | Optical information recording medium | Ricoh Company, Ltd (JP) | 1985-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033490-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING CHRNA6 INHIBITORS | CHRNA6, CHRNA1, CHRNB1 | SLC6A2 189/4885SLC6A4 510/4885SLC6A3 509/4885 |
| US-20100048893-A1 | Substituted arylalkanoic acid derivatives and use thereof | CYSLTR1, CYSLTR2, LTB4R2 | SLC6A2 3092/4885SLC6A4 1621/4885SLC6A3 2005/4885 |
| US-12569679-B2 | Treatment delivery system | PIEZO1, DSG1, KRT18 | SLC6A2 345/4885SLC6A4 575/4885SLC6A3 1967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.